Advances in radiotherapy and immunity in hepatocellular carcinoma

Primary liver cancer is one of the most common malignant tumours worldwide; it caused approximately 830,000 deaths in 2020. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, accounting for over 80% of all cases. Various methods, including surgery, chemotherapy, radiothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yuhan, Xiong, Liting, Li, Mengyuan, Jiang, Ping, Wang, Junjie, Li, Chunxiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401766/
https://www.ncbi.nlm.nih.gov/pubmed/37542324
http://dx.doi.org/10.1186/s12967-023-04386-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401766/
https://www.ncbi.nlm.nih.gov/pubmed/37542324
http://dx.doi.org/10.1186/s12967-023-04386-y

Ejemplares similares